Vimarsana
Biggest News Aggregation in the World

Zymeworks Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Zymeworks Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Zymeworks Inc Today - Breaking & Trending Today

Zymeworks Inc. (ZYME) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates - Vimarsana News

Zymeworks Inc. (ZYME) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates

NEW YORK, NY / ACCESSWIRE / May 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zymeworks Inc. (&quot...

Zymeworks Announces Participation in Upcoming Investor Conferences - Vimarsana News

Zymeworks Announces Participation in Upcoming Investor Conferences

VANCOUVER, British Columbia, May 28, 2024 -- Zymeworks Inc. , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard...

Zymeworks Inc.: Zymeworks Announces Participation in Upcoming Investor Conferences - Vimarsana News

Zymeworks Inc.: Zymeworks Announces Participation in Upcoming Investor Conferences

VANCOUVER, British Columbia, May 28, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics

Bragar Eagel & Squire, P.C. Is Investigating Zymeworks, - Vimarsana News

Bragar Eagel & Squire, P.C. Is Investigating Zymeworks,

NEW YORK, May 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating...

Bragar Eagel & Squire, P.C. Is Investigating Zymeworks, Regeneron, Jabil, and DoubleVerify ... - Vimarsana News

Bragar Eagel & Squire, P.C. Is Investigating Zymeworks, Regeneron, Jabil, and DoubleVerify ...

NEW YORK, May 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zymeworks Inc. (NASDAQ: ZYME), Regeneron